Short interest in Monopar Therapeutics Inc (NASDAQ:MNPR) increased during the last reporting period, rising from 49.85K to 72.01K. This put 14.76% of the company's publicly available shares short.

Short interest for Monopar Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Monopar Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.27M shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.